These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 30340569)
81. Marital status is an independent prognostic factor for pancreatic neuroendocrine tumors patients: An analysis of the Surveillance, Epidemiology, and End Results (SEER) database. Zhou H; Zhang Y; Song Y; Tan W; Qiu Z; Li S; Chen Q; Gao S Clin Res Hepatol Gastroenterol; 2017 Sep; 41(4):476-486. PubMed ID: 28416359 [TBL] [Abstract][Full Text] [Related]
82. Predicting the survival of patients with pancreatic neuroendocrine neoplasms using deep learning: A study based on Surveillance, Epidemiology, and End Results database. Jiang C; Wang K; Yan L; Yao H; Shi H; Lin R Cancer Med; 2023 Jun; 12(11):12413-12424. PubMed ID: 37165971 [TBL] [Abstract][Full Text] [Related]
83. Metastatic pancreatic adenocarcinomas could be classified into M1a and M1b category by the number of metastatic organs. Feng F; Cai W; Wang G; Chen W; Yang H; Sun M; Zhou L BMC Gastroenterol; 2020 Aug; 20(1):289. PubMed ID: 32854631 [TBL] [Abstract][Full Text] [Related]
84. Age in combination with gender is a valuable parameter in differential diagnosis of solid pseudopapillary tumors and pancreatic neuroendocrine neoplasm. Wu L; Zou T; Shi D; Cheng H; Shahbaz M; Umar M; Li T; Zhang X; Gong P; Wei Y BMC Endocr Disord; 2022 Oct; 22(1):255. PubMed ID: 36271376 [TBL] [Abstract][Full Text] [Related]
85. [Multivariate saturation treatment for pancreatic neuroendocrine neoplasms with liver metastasis]. Liu R; Shen XF; Liu Q Zhonghua Yi Xue Za Zhi; 2021 Aug; 101(32):2497-2501. PubMed ID: 34407573 [TBL] [Abstract][Full Text] [Related]
86. Revised classification of neuroendocrine tumours of the lung, pancreas and gut. Capella C; Heitz PU; Höfler H; Solcia E; Klöppel G Virchows Arch; 1995; 425(6):547-60. PubMed ID: 7697211 [TBL] [Abstract][Full Text] [Related]
87. Unmet Needs in the Field of Neuroendocrine Neoplasms of the Gastrointestinal Tract, Pancreas, and Respiratory System: Reports by the ENETS Group. de Herder WW; Capdevila J Neuroendocrinology; 2019; 108(1):5-6. PubMed ID: 30517944 [No Abstract] [Full Text] [Related]
88. [Pancreatic tumor: progress in diagnosis and treatment. Topics: III. Pancreatic endocrine tumor; 1. Epidemiology, symptoms and diagnosis]. Igarashi H; Fujimori N; Ito T Nihon Naika Gakkai Zasshi; 2012 Jan; 101(1):100-8. PubMed ID: 22413467 [No Abstract] [Full Text] [Related]
89. Chromothripsis is a novel biomarker for prognosis and differentiation diagnosis of pancreatic neuroendocrine neoplasms. Zhang MY; He D; Zhang Y; Cheng K; Li HS; Zhou YW; Long QX; Liu RZ; Liu JY MedComm (2020); 2024 Jul; 5(7):e623. PubMed ID: 38988495 [TBL] [Abstract][Full Text] [Related]
90. Pancreatic Neuroendocrine Neoplasms Larger than 4 cm: A Retrospective Observational Study of Surgery, Histology, and Outcome. Milanetto AC; Gais Zürcher AL; David A; Fassan M; Pasquali C J Clin Med; 2023 Feb; 12(5):. PubMed ID: 36902627 [TBL] [Abstract][Full Text] [Related]
91. Characteristics and risk differences of different tumor sizes on distant metastases of pancreatic neuroendocrine tumors: A retrospective study in the SEER database. Dong SC; Tang QY; Wang L; Fang F; Bai DS; Jin SJ; Zhou BH; Jiang GQ Hepatobiliary Pancreat Dis Int; 2024 Jul; ():. PubMed ID: 39019667 [TBL] [Abstract][Full Text] [Related]
92. Second Primary Malignancies in Patients with Pancreatic Neuroendocrine Neoplasms: A Population-Based Study on Occurrence, Risk Factors, and Prognosis. Hu T; Wang W; He C J Oncol; 2021; 2021():1565089. PubMed ID: 34754307 [TBL] [Abstract][Full Text] [Related]